Hydralazine

This classification denotes an antihypertensive agent with the molecular formula C8H8N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26NAK24LS8, chemically known as 1 (2h)-phthalazinone, hydrazone, monohydrochloride but generally known as hydralazine, which bears US NIH Compound Identifier 3637. European Medicines Agency schedules Hydralazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08059MIG. The term HYDRALAZINE is an International Non-Proprietary Name. World Health Organization schedules hydralazine in its Anatomical Therapeutic Chemical (ATC) Classification. HYDRALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hydralazine under HS 29339990 and SITC 51577. As of Q4 2014, HYDRALAZINE remains the US FDA Preferred Term for this commodity. Hydralazine bears US NLM identifiers UMLS ID C0020223 and NCI Concept Code C62032. SMILES: N(N)c1nncc2c1cccc2.